Diana C. Dinh, MD

Associate Professor of Radiology
Beth Israel Deaconess Medical Center, United States

Presentation(s):

• Changing Utilization of Locoregional Therapies for HCC Across the United States

  Sunday, April 12, 2026
  3:00 PM - 3:09 PM ET

• Target Trial Emulation: A Comparison of Resection, Ablation, and TARE for Early-Stage HCC – a Real-World Analysis

  Sunday, April 12, 2026
  3:09 PM - 3:18 PM ET

• Socioeconomic Factors Influencing Treatment Receipt of HCC : A Nationwide Analysis

  Monday, April 13, 2026
  3:54 PM - 4:03 PM ET

• Comparative Voxel-Based Dosimetry of Underdosed Tumor Volume and Tumor Absorbed Dose Between Tc-MAA SPECT/CT and 90Y PET/CT in HCC Patients Treated with Radiation Segmentectomy

  Monday, April 13, 2026
  3:36 PM - 3:45 PM ET

• Comparison of Size- and Enhancement-Based Criteria for Evaluating Treatment Response and Survival Outcomes in Intrahepatic Cholangiocarcinoma Patients Treated with Yttrium-90 Radioembolization

  Tuesday, April 14, 2026
  3:00 PM - 3:09 PM ET

• Voxel-based Dosimetry and Activity Deposition Pattern Predicting Survival and Progression Outcomes in Intrahepatic Cholangiocarcinoma Patients Treated with Yttrium-90 Radioembolization Using Resin Microspheres

  Tuesday, April 14, 2026
  3:45 PM - 3:54 PM ET

• Histopathologic Analysis of Intrahepatic Cholangiocarcinoma Treated with Transarterial Radioembolization Using Yttrium-90 Resin Microspheres

  Wednesday, April 15, 2026
  11:24 AM - 11:33 AM ET

• Volume of Under-Dosed Tumor Predicts Survival After Radiation Segmentectomy of Hepatocellular Carcinoma Using Resin Microspheres

  Wednesday, April 15, 2026
  11:33 AM - 11:42 AM ET